LEFT-VENTRICULAR WALL-MOTION ABNORMALITIES IN 80 PATIENTS WITH SYSTEMIC-SCLEROSIS

被引：27
作者：
HEGEDUS, I [1 ]
CZIRJAK, L [1 ]
机构：
[1] DEBRECEN UNIV MED,SCH MED,DEPT HEART & LUNG DIS,H-4012 DEBRECEN,HUNGARY
来源：
CLINICAL RHEUMATOLOGY | 1995年 / 14卷 / 02期
关键词：
SCLERODERMA; SYSTEMIC SCLEROSIS; CLINICAL STUDY; MYOCARDIUM; HEART;
D O I：
10.1007/BF02214936
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Segmental analysis of left ventricular wall motion was performed in 80 patients with systemic sclerosis by echocardiography. Half of the cases showed normal wall motion. Eighteen of the 57 patients with limited cutaneous systemic sclerosis (31.6%) exhibited hypokinetic wall motion abnormalities, while five of the 23 cases with diffuse cutaneous systemic sclerosis (21.7%) had similar findings. The three cases showing akinesis also belonged to the limited scleroderma subgroup. Our findings show that hypokinetic wall motion abnormalities can be detected in a remarkably high proportion of cases with limited cutaneous systemic sclerosis.
引用
收藏
页码：161 / 164
页数：4
相关论文
共 15 条
  • [1] Clements P.J., Lachenbruch P.A., Furst D.E., Paulus H.E., Sterz M.G., Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis, Arthritis Rheum, 34, pp. 1371-1380, (1991)
  • [2] D'Angelo W.A., Fries J.F., Masi A.T., Shulman L.E., Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls, Am J Med, 46, pp. 428-440, (1969)
  • [3] Hegedus I., Czirjak L., Left ventricular wall thickness and disease duration in systemic sclerosis, Postgrad Med J, 69, pp. 291-295, (1993)
  • [4] Follansbee W.P., Miller T.R., Curtiss E.I., Et al., A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma), J Rheumatol, 17, pp. 656-662, (1990)
  • [5] Follansbee W.P., Curtiss E.I., Medsger T.A.J., Et al., Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma, N Engl J Med, 310, pp. 142-148, (1984)
  • [6] Hegedus I., Czirjak L., Septum and posterior wall thickness and disease duration in systemic sclerosis, J Intern Med, 229, pp. 383-384, (1991)
  • [7] Alpert M.A., Pressly T.A., Mukerji V., Et al., Acute and longterm effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease, Am J Cardiol, 68, pp. 1687-1691, (1991)
  • [8] Wynn J., Fineberg N., Matzer L., Et al., Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features, Am Heart J, 110, pp. 123-127, (1985)
  • [9] Czirjak L., Nagy Z., Szegedi G., Survival analysis of 118 patients with systemic sclerosis, Journal of Internal Medicine, 234, pp. 335-337, (1993)
  • [10] Heger J.J., Weyman A.E., Wann L.S., Dillon J.C., Feigenbaum H., Cross-sectional echocardiography in acute myocardial infarction: detection and localisation of regional left ventricular asynergy, Circulation, 60, pp. 531-538, (1979)
12